Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. حسب Thomas Hanslmeier (19949694)

الموضوعات:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. حسب Thomas Hanslmeier (19949694)

الموضوعات:

UTI diagnoses by sex and physician specialty (2013–2019). حسب Thomas Hanslmeier (19949694)

الموضوعات:

Uronic acid analysis-based screen identified IFA as an effective capsule inhibitor. حسب Tingting Wang (123983)

الموضوعات:

IFA did not affect LPS-induced inflammation response. حسب Tingting Wang (123983)

الموضوعات:

IFA reduced the capsular biosynthesis through altering bacterial metabolism. حسب Tingting Wang (123983)

الموضوعات:

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. حسب Tingting Wang (123983)

الموضوعات:

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. حسب Tingting Wang (123983)

الموضوعات:

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. حسب Tingting Wang (123983)

الموضوعات:

IFA disarmed capsule-mediated immune evasion. حسب Tingting Wang (123983)

الموضوعات:

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. حسب Tingting Wang (123983)

الموضوعات:

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. حسب Tingting Wang (123983)

الموضوعات:

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. حسب Tingting Wang (123983)

الموضوعات:

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. حسب Tingting Wang (123983)

الموضوعات:

Parameters for the treadmill during the acclimatization period. حسب Wenbin Wu (292223)

الموضوعات:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. حسب Wenbin Wu (292223)

الموضوعات: